Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study | Zendy

Ya-Hsu Yang | Zendy; Jen Kou Lin | Zendy; Wei Shone Chen | Zendy; Tzu Chen Lin | Zendy; Shung-Haur Yang | Zendy; Jeng Kai Jiang | Zendy; Shih Ching Chang | Zendy; Yuan Lan | Zendy; Chun Chi Lin | Zendy; Chueh Chuan Yen | Zendy; Cheng-Hwai Tzeng | Zendy; Wei Shu Wang | Zendy; HueyLing Chiang | Zendy; Chung Jen Teng | Zendy; Hao-Wei Teng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study

Author(s) -

Ya-Hsu Yang,

Jen Kou Lin,

Wei Shone Chen,

Tzu Chen Lin,

Shung-Haur Yang,

Jeng Kai Jiang,

Shih Ching Chang,

Yuan Lan,

Chun Chi Lin,

Chueh Chuan Yen,

Cheng-Hwai Tzeng,

Wei Shu Wang,

HueyLing Chiang,

Chung Jen Teng,

Hao-Wei Teng

Publication year - 2011

Publication title -

supportive care in cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.133

H-Index - 112

eISSN - 1433-7339

pISSN - 0941-4355

DOI - 10.1007/s00520-011-1237-2

Subject(s) - duloxetine , medicine , oxaliplatin , tolerability , adverse effect , chemotherapy induced peripheral neuropathy , visual analogue scale , neuropathic pain , peripheral neuropathy , colorectal cancer , duloxetine hydrochloride , anesthesia , cancer , diabetes mellitus , alternative medicine , pathology , endocrinology

This open-label pilot study is aimed to evaluate the efficacy and tolerability of the antidepressant duloxetine, which is effective for diabetic neuropathic pain, in the treatment of chronic oxaliplatin-induced peripheral neuropathy (OIPN).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research